Literature DB >> 34114182

The Prognostic Value of Lymph Node Ratio in Locally Advanced Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy.

Kazuki Kano1,2, Takanobu Yamada1,2, Keisuke Komori1,2, Hayato Watanabe1,2, Kosuke Takahashi1, Hirohito Fujikawa1,2, Masakatsu Numata2, Toru Aoyama2, Hiroshi Tamagawa2, Norio Yukawa2, Yasushi Rino2, Munetaka Masuda2, Takashi Ogata1, Takashi Oshima3.   

Abstract

BACKGROUND: The lymph node (LN) ratio (LNR) has been proposed as a sensitive prognosticator in patients with esophageal squamous cell carcinoma (ESCC), especially when the number of LNs harvested is insufficient. We investigated the association between the LNR and survival in patients with locally advanced ESCC who received neoadjuvant chemotherapy (NAC) and explored whether the LNR is a prognosticator in these patients when stratified by their response to NAC.
METHODS: We retrospectively reviewed 199 locally advanced ESCC patients who received curative resection after NAC between January 2011 and December 2019. The predictive accuracy of the adjusted X-tile cut-off values for LNR of 0 and 0.13 was compared with that in the Union for International Cancer Control pathological N (UICC pN) categories. The association between survival rate and clinicopathological features was examined.
RESULTS: Multivariate analysis identified that the LNR was an independent risk factor for recurrence-free survival [RFS; hazard ratio (HR) 6.917, p < 0.001] and overall survival (OS) (HR 4.998, p < 0.001). Moreover, even when stratified by response to NAC, the LNR was a significant independent risk factor for RFS and OS (p < 0.001). The receiver operating characteristic curves identified that the prognostic accuracy of the LNR tended to be better than that of the UICC pN factor in all cases and responders.
CONCLUSION: The LNR had a significant prognostic value in patients with locally advanced ESCC, including in those who received NAC.

Entities:  

Year:  2021        PMID: 34114182     DOI: 10.1245/s10434-021-10240-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

1.  EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran.

Authors:  Kazem Anvari; Hamid R Sima; Mehdi Seilanian Toussi; Azam Anvari; Soodabeh Shahidsales; Bahram Memar; Seyed Amir Aledavoud; Mohammad N Forghani; Abbas Abdollahi; Kamran Ghaffarzadegan
Journal:  Arch Iran Med       Date:  2017-04       Impact factor: 1.354

2.  Response to the Comment on "Pathological Regression of Lymph Nodes Better Predicts Long-Term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery".

Authors:  Tomoki Makino; Takaomi Hagi; Yuichiro Doki
Journal:  Ann Surg       Date:  2021-12-01       Impact factor: 12.969

  2 in total
  1 in total

1.  ASO Author Reflections: Lymph Node Ratio After Neoadjuvant Chemotherapy in Locally Advanced Esophageal Cancer.

Authors:  Kazuki Kano; Takanobu Yamada; Takashi Ogata; Takashi Oshima
Journal:  Ann Surg Oncol       Date:  2021-07-01       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.